TXG – 10x genomics, inc. (US:NASDAQ)
Stock Stats
News
Spatial Genomics and Transcriptomics Research Analysis Report 2024-2030: Emergence of High-Throughput Sequencing Platforms Fuels Market Growth [Yahoo! Finance]
Sphere Fluidics Strengthens Global Commercial Teams and Establishes Direct Sales and Support Channel in North America [Yahoo! Finance]
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Barclays PLC from $21.00 to $19.00. They now have an "overweight" rating on the stock.
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance]
Form 4 10x Genomics, Inc. For: Nov 14 Filed by: Saxonov Serge
Form SC 13G 10x Genomics, Inc. Filed by: Nikko Asset Management Americas, Inc.
Form SC 13G 10x Genomics, Inc. Filed by: Sumitomo Mitsui Trust Group, Inc.
Form 10-Q 10x Genomics, Inc. For: Sep 30
Form 8-K 10x Genomics, Inc. For: Oct 24
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.